Huntington Potter
Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 41 | 2024 | 516 | 7.100 |
Why?
| Amyloid beta-Peptides | 22 | 2022 | 211 | 3.560 |
Why?
| Electroporation | 8 | 2018 | 37 | 2.770 |
Why?
| Transfection | 10 | 2018 | 918 | 2.430 |
Why?
| Cognition Disorders | 13 | 2012 | 505 | 2.060 |
Why?
| Amyloid beta-Protein Precursor | 14 | 2022 | 61 | 1.590 |
Why?
| Cognitive Dysfunction | 6 | 2020 | 347 | 1.420 |
Why?
| Down Syndrome | 8 | 2024 | 478 | 1.290 |
Why?
| tau Proteins | 4 | 2019 | 77 | 1.260 |
Why?
| Aneuploidy | 4 | 2017 | 92 | 1.220 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2023 | 147 | 1.180 |
Why?
| Neuropsychological Tests | 14 | 2020 | 1016 | 1.170 |
Why?
| Cognition | 11 | 2022 | 1125 | 1.120 |
Why?
| Chromosome Segregation | 3 | 2013 | 42 | 1.000 |
Why?
| Mice, Transgenic | 19 | 2018 | 2135 | 0.910 |
Why?
| Apolipoprotein E4 | 3 | 2022 | 35 | 0.870 |
Why?
| Neurons | 6 | 2017 | 1509 | 0.860 |
Why?
| West Nile Fever | 2 | 2023 | 51 | 0.840 |
Why?
| Apolipoproteins E | 7 | 2019 | 77 | 0.820 |
Why?
| Spindle Apparatus | 3 | 2013 | 95 | 0.790 |
Why?
| Dementia | 6 | 2012 | 227 | 0.790 |
Why?
| Immune System | 2 | 2022 | 175 | 0.780 |
Why?
| Exosomes | 2 | 2020 | 97 | 0.760 |
Why?
| Extracellular Vesicles | 1 | 2024 | 129 | 0.760 |
Why?
| Brain | 14 | 2024 | 2677 | 0.730 |
Why?
| Peptide Fragments | 6 | 2022 | 695 | 0.710 |
Why?
| Caffeine | 4 | 2012 | 62 | 0.710 |
Why?
| Ultracentrifugation | 1 | 2020 | 48 | 0.690 |
Why?
| Psychiatric Status Rating Scales | 5 | 2012 | 534 | 0.680 |
Why?
| Apathy | 1 | 2020 | 6 | 0.680 |
Why?
| Animals | 39 | 2023 | 35409 | 0.670 |
Why?
| Temporal Lobe | 6 | 2012 | 86 | 0.660 |
Why?
| Hippocampus | 7 | 2022 | 844 | 0.650 |
Why?
| Presenilin-1 | 6 | 2016 | 31 | 0.630 |
Why?
| Mice | 26 | 2023 | 16983 | 0.610 |
Why?
| Alzheimer Vaccines | 2 | 2008 | 2 | 0.600 |
Why?
| Disease Models, Animal | 15 | 2022 | 4077 | 0.580 |
Why?
| Frontotemporal Lobar Degeneration | 1 | 2017 | 10 | 0.570 |
Why?
| Central Nervous System Stimulants | 3 | 2009 | 154 | 0.560 |
Why?
| Gene Expression | 5 | 2020 | 1465 | 0.560 |
Why?
| Nanoparticles | 1 | 2020 | 376 | 0.510 |
Why?
| Amyloid | 3 | 2021 | 85 | 0.510 |
Why?
| Uniparental Disomy | 1 | 2016 | 8 | 0.500 |
Why?
| Islet Amyloid Polypeptide | 3 | 2021 | 46 | 0.500 |
Why?
| alpha 1-Antichymotrypsin | 2 | 2006 | 4 | 0.500 |
Why?
| Microtubule-Associated Proteins | 2 | 2015 | 192 | 0.480 |
Why?
| Pneumonia, Viral | 1 | 2020 | 342 | 0.480 |
Why?
| Coronavirus Infections | 1 | 2020 | 336 | 0.470 |
Why?
| Trisomy | 1 | 2016 | 77 | 0.470 |
Why?
| Atrophy | 8 | 2011 | 170 | 0.470 |
Why?
| DNA | 3 | 2018 | 1406 | 0.470 |
Why?
| Axonal Transport | 1 | 2015 | 26 | 0.470 |
Why?
| Cells, Cultured | 12 | 2020 | 4102 | 0.470 |
Why?
| Astrocytes | 3 | 2022 | 197 | 0.470 |
Why?
| Plasma | 2 | 2024 | 206 | 0.460 |
Why?
| Bacteriophage phi X 174 | 1 | 2014 | 5 | 0.460 |
Why?
| Molecular Biology | 1 | 2014 | 57 | 0.450 |
Why?
| Receptors, Neurotransmitter | 1 | 2014 | 17 | 0.440 |
Why?
| Maze Learning | 7 | 2010 | 101 | 0.440 |
Why?
| Protoplasts | 5 | 2018 | 7 | 0.430 |
Why?
| Humans | 55 | 2024 | 129847 | 0.430 |
Why?
| DNA, Viral | 2 | 2021 | 347 | 0.430 |
Why?
| Proteomics | 1 | 2020 | 1058 | 0.430 |
Why?
| Nerve Growth Factors | 1 | 2014 | 75 | 0.430 |
Why?
| Niemann-Pick Disease, Type C | 1 | 2013 | 2 | 0.420 |
Why?
| Mitosis | 2 | 2011 | 180 | 0.420 |
Why?
| Mutation | 6 | 2017 | 3706 | 0.410 |
Why?
| DNA Replication | 1 | 2014 | 225 | 0.400 |
Why?
| Aged | 21 | 2023 | 22107 | 0.350 |
Why?
| Molecular Motor Proteins | 1 | 2011 | 35 | 0.350 |
Why?
| Cholesterol, LDL | 1 | 2013 | 358 | 0.350 |
Why?
| Apoptosis | 2 | 2017 | 2489 | 0.340 |
Why?
| White Matter | 2 | 2023 | 135 | 0.340 |
Why?
| Memory, Episodic | 2 | 2021 | 48 | 0.330 |
Why?
| Chromosomes, Mammalian | 1 | 2009 | 25 | 0.330 |
Why?
| Receptors, LDL | 1 | 2010 | 47 | 0.330 |
Why?
| Neuropharmacology | 1 | 2009 | 5 | 0.320 |
Why?
| Amyloidosis | 1 | 2010 | 42 | 0.320 |
Why?
| Infusion Pumps, Implantable | 1 | 2009 | 23 | 0.320 |
Why?
| Plants | 4 | 2018 | 218 | 0.320 |
Why?
| Disease Progression | 6 | 2012 | 2628 | 0.320 |
Why?
| Catheters, Indwelling | 1 | 2009 | 80 | 0.310 |
Why?
| Checklist | 1 | 2010 | 94 | 0.310 |
Why?
| Multicenter Studies as Topic | 1 | 2010 | 287 | 0.310 |
Why?
| Atherosclerosis | 1 | 2013 | 402 | 0.300 |
Why?
| Aged, 80 and over | 13 | 2021 | 7066 | 0.290 |
Why?
| Magnetic Resonance Imaging | 9 | 2012 | 3397 | 0.290 |
Why?
| Encephalitis | 3 | 2020 | 131 | 0.270 |
Why?
| Herpes Zoster | 2 | 2021 | 317 | 0.260 |
Why?
| Activities of Daily Living | 1 | 2009 | 384 | 0.250 |
Why?
| Environment | 3 | 2007 | 345 | 0.250 |
Why?
| Memory | 2 | 2020 | 241 | 0.240 |
Why?
| Genetic Loci | 2 | 2019 | 274 | 0.240 |
Why?
| Mice, Inbred C57BL | 7 | 2017 | 5468 | 0.230 |
Why?
| Dendritic Cells | 1 | 2008 | 481 | 0.230 |
Why?
| Gliosis | 2 | 2023 | 28 | 0.230 |
Why?
| Intermediate Filament Proteins | 1 | 2004 | 57 | 0.230 |
Why?
| Amyloidogenic Proteins | 1 | 2024 | 16 | 0.220 |
Why?
| Reproducibility of Results | 5 | 2010 | 3089 | 0.220 |
Why?
| Genotype | 7 | 2017 | 1829 | 0.220 |
Why?
| Algorithms | 2 | 2012 | 1617 | 0.210 |
Why?
| Muscles | 2 | 2017 | 320 | 0.210 |
Why?
| Analysis of Variance | 4 | 2010 | 1291 | 0.210 |
Why?
| Peptides | 2 | 2024 | 926 | 0.200 |
Why?
| Female | 24 | 2023 | 68829 | 0.200 |
Why?
| Cytokines | 4 | 2022 | 2022 | 0.200 |
Why?
| Cell Culture Techniques | 2 | 2018 | 349 | 0.200 |
Why?
| Imipramine | 1 | 2022 | 12 | 0.200 |
Why?
| Cell Line | 3 | 2017 | 2780 | 0.190 |
Why?
| Plant Cells | 3 | 2010 | 5 | 0.190 |
Why?
| Genetic Predisposition to Disease | 5 | 2019 | 2271 | 0.190 |
Why?
| Predictive Value of Tests | 4 | 2011 | 1951 | 0.190 |
Why?
| Polymerization | 1 | 2022 | 124 | 0.190 |
Why?
| Catalysis | 1 | 2022 | 312 | 0.180 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2022 | 149 | 0.180 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 836 | 0.180 |
Why?
| Arteritis | 1 | 2021 | 26 | 0.180 |
Why?
| Cerebral Cortex | 1 | 2004 | 439 | 0.180 |
Why?
| Arthritis, Rheumatoid | 1 | 2010 | 1098 | 0.180 |
Why?
| Interneurons | 1 | 2022 | 120 | 0.180 |
Why?
| Chemical Precipitation | 1 | 2020 | 37 | 0.170 |
Why?
| Healthy Aging | 1 | 2021 | 34 | 0.170 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2021 | 91 | 0.170 |
Why?
| Protein Aggregation, Pathological | 1 | 2020 | 16 | 0.170 |
Why?
| Herpesvirus 3, Human | 2 | 2021 | 331 | 0.160 |
Why?
| Varicella Zoster Virus Infection | 1 | 2020 | 25 | 0.160 |
Why?
| Plaque, Amyloid | 3 | 2011 | 15 | 0.160 |
Why?
| Homozygote | 2 | 2017 | 195 | 0.160 |
Why?
| Male | 20 | 2021 | 63759 | 0.160 |
Why?
| Skin | 2 | 2017 | 725 | 0.160 |
Why?
| Early Diagnosis | 2 | 2011 | 233 | 0.160 |
Why?
| Microglia | 2 | 2023 | 234 | 0.160 |
Why?
| Neurites | 2 | 2023 | 47 | 0.160 |
Why?
| Gene Dosage | 2 | 2017 | 143 | 0.160 |
Why?
| Case-Control Studies | 6 | 2020 | 3384 | 0.160 |
Why?
| Immunity | 1 | 2019 | 138 | 0.150 |
Why?
| Brain Mapping | 2 | 2012 | 575 | 0.150 |
Why?
| Epitope Mapping | 2 | 2008 | 58 | 0.150 |
Why?
| Gene Knock-In Techniques | 1 | 2018 | 53 | 0.140 |
Why?
| Thiones | 2 | 2016 | 14 | 0.140 |
Why?
| Blotting, Western | 3 | 2011 | 1204 | 0.140 |
Why?
| Phospholipase C gamma | 1 | 2017 | 29 | 0.140 |
Why?
| Gene Knockout Techniques | 1 | 2018 | 109 | 0.140 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2009 | 81 | 0.140 |
Why?
| Phosphodiesterase Inhibitors | 2 | 2009 | 89 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 252 | 0.140 |
Why?
| Calcium | 2 | 2014 | 1212 | 0.140 |
Why?
| Heterozygote | 1 | 2017 | 271 | 0.130 |
Why?
| Attention | 1 | 2020 | 439 | 0.130 |
Why?
| Transgenes | 1 | 2017 | 178 | 0.130 |
Why?
| Lithium Chloride | 1 | 2016 | 12 | 0.130 |
Why?
| Receptors, Immunologic | 1 | 2017 | 216 | 0.130 |
Why?
| Mammals | 2 | 2011 | 274 | 0.130 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2016 | 43 | 0.120 |
Why?
| Neuroimaging | 2 | 2023 | 279 | 0.120 |
Why?
| Long-Term Potentiation | 2 | 2016 | 192 | 0.120 |
Why?
| Executive Function | 1 | 2020 | 433 | 0.120 |
Why?
| Dendritic Spines | 1 | 2016 | 62 | 0.120 |
Why?
| Mosaicism | 1 | 2016 | 69 | 0.120 |
Why?
| Functional Laterality | 3 | 2012 | 221 | 0.120 |
Why?
| Mice, Inbred BALB C | 2 | 2008 | 1248 | 0.120 |
Why?
| Lipids | 1 | 2019 | 628 | 0.120 |
Why?
| Membrane Glycoproteins | 1 | 2017 | 477 | 0.120 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 399 | 0.110 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2017 | 2062 | 0.110 |
Why?
| Genome-Wide Association Study | 3 | 2019 | 1326 | 0.110 |
Why?
| Recombinant Proteins | 2 | 2023 | 1311 | 0.110 |
Why?
| PC12 Cells | 1 | 2014 | 40 | 0.110 |
Why?
| Microscopy, Electron | 1 | 2014 | 425 | 0.110 |
Why?
| Nerve Growth Factor | 1 | 2014 | 27 | 0.110 |
Why?
| Pyrimidines | 2 | 2016 | 458 | 0.110 |
Why?
| History, 21st Century | 1 | 2014 | 186 | 0.110 |
Why?
| Amnesia | 2 | 2012 | 42 | 0.110 |
Why?
| Biomarkers | 3 | 2022 | 3971 | 0.110 |
Why?
| Middle Aged | 10 | 2021 | 31177 | 0.110 |
Why?
| Membrane Fluidity | 1 | 2013 | 11 | 0.100 |
Why?
| History, 20th Century | 1 | 2014 | 295 | 0.100 |
Why?
| Risk Factors | 6 | 2014 | 9801 | 0.100 |
Why?
| Immunohistochemistry | 4 | 2011 | 1690 | 0.100 |
Why?
| Anxiety | 1 | 2020 | 976 | 0.100 |
Why?
| Pancreatitis, Alcoholic | 1 | 2012 | 2 | 0.100 |
Why?
| Trypsinogen | 1 | 2012 | 10 | 0.100 |
Why?
| Cell Cycle | 1 | 2016 | 583 | 0.100 |
Why?
| Claudins | 1 | 2012 | 25 | 0.100 |
Why?
| Trypsin | 1 | 2012 | 74 | 0.100 |
Why?
| Memory Disorders | 2 | 2012 | 162 | 0.100 |
Why?
| Enzyme Inhibitors | 1 | 2016 | 827 | 0.100 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 210 | 0.100 |
Why?
| Neuroglia | 1 | 2013 | 167 | 0.090 |
Why?
| Brain Chemistry | 1 | 2012 | 118 | 0.090 |
Why?
| Glutamic Acid | 1 | 2014 | 235 | 0.090 |
Why?
| Pandemics | 1 | 2020 | 1500 | 0.090 |
Why?
| Follow-Up Studies | 2 | 2011 | 4896 | 0.090 |
Why?
| Centrosome | 1 | 2011 | 64 | 0.090 |
Why?
| Parkinsonian Disorders | 1 | 2011 | 34 | 0.090 |
Why?
| Entorhinal Cortex | 1 | 2011 | 10 | 0.090 |
Why?
| Immunity, Innate | 1 | 2017 | 804 | 0.090 |
Why?
| Longitudinal Studies | 4 | 2012 | 2724 | 0.090 |
Why?
| Neuronal Plasticity | 1 | 2014 | 278 | 0.090 |
Why?
| Age Factors | 2 | 2009 | 3161 | 0.090 |
Why?
| Xenopus | 1 | 2011 | 85 | 0.090 |
Why?
| Myocytes, Smooth Muscle | 1 | 2013 | 259 | 0.090 |
Why?
| Inflammation | 1 | 2022 | 2748 | 0.090 |
Why?
| Mice, Knockout | 2 | 2010 | 2888 | 0.090 |
Why?
| Molecular Targeted Therapy | 1 | 2014 | 391 | 0.090 |
Why?
| Vaccines, DNA | 1 | 2010 | 28 | 0.090 |
Why?
| Oocytes | 1 | 2011 | 171 | 0.080 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2010 | 17 | 0.080 |
Why?
| Adult | 4 | 2024 | 35634 | 0.080 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 73 | 0.080 |
Why?
| Serine Proteinase Inhibitors | 1 | 2009 | 42 | 0.080 |
Why?
| Florida | 1 | 2009 | 93 | 0.080 |
Why?
| Homeostasis | 1 | 2013 | 605 | 0.080 |
Why?
| Observer Variation | 1 | 2010 | 314 | 0.080 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2009 | 45 | 0.080 |
Why?
| Microdialysis | 1 | 2009 | 51 | 0.080 |
Why?
| Theophylline | 1 | 2009 | 68 | 0.080 |
Why?
| Cell Line, Transformed | 1 | 2009 | 139 | 0.080 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 307 | 0.080 |
Why?
| Geriatric Assessment | 1 | 2010 | 205 | 0.080 |
Why?
| Drug Synergism | 1 | 2009 | 370 | 0.070 |
Why?
| Genetic Therapy | 1 | 2010 | 293 | 0.070 |
Why?
| Tubulin | 1 | 2010 | 138 | 0.070 |
Why?
| Ethanol | 1 | 2013 | 591 | 0.070 |
Why?
| Psychomotor Performance | 2 | 2009 | 312 | 0.070 |
Why?
| Antibody Specificity | 1 | 2008 | 185 | 0.070 |
Why?
| Drug Interactions | 1 | 2009 | 397 | 0.070 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 133 | 0.070 |
Why?
| Fibroblasts | 1 | 2013 | 954 | 0.070 |
Why?
| Time Factors | 2 | 2009 | 6550 | 0.070 |
Why?
| Cell Cycle Proteins | 1 | 2011 | 583 | 0.070 |
Why?
| Cross Reactions | 1 | 2008 | 133 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 954 | 0.070 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 284 | 0.070 |
Why?
| Genetic Variation | 1 | 2012 | 937 | 0.070 |
Why?
| Blood | 1 | 2007 | 105 | 0.070 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 68 | 0.070 |
Why?
| Exploratory Behavior | 1 | 2007 | 87 | 0.070 |
Why?
| Aging | 2 | 2009 | 1774 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 291 | 0.070 |
Why?
| t-Complex Genome Region | 1 | 2006 | 3 | 0.070 |
Why?
| Bone Marrow | 1 | 2008 | 272 | 0.070 |
Why?
| Up-Regulation | 1 | 2010 | 836 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 766 | 0.070 |
Why?
| Supranuclear Palsy, Progressive | 1 | 2006 | 11 | 0.070 |
Why?
| Platelet-Derived Growth Factor | 1 | 2006 | 89 | 0.070 |
Why?
| Rolipram | 1 | 2006 | 3 | 0.070 |
Why?
| In Situ Nick-End Labeling | 1 | 2006 | 123 | 0.070 |
Why?
| Silver Staining | 1 | 2006 | 17 | 0.060 |
Why?
| Retrospective Studies | 2 | 2022 | 14553 | 0.060 |
Why?
| Valine | 1 | 2006 | 81 | 0.060 |
Why?
| Phosphorylation | 2 | 2011 | 1716 | 0.060 |
Why?
| Problem Solving | 1 | 2007 | 153 | 0.060 |
Why?
| Methionine | 1 | 2006 | 155 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 170 | 0.060 |
Why?
| Immunologic Memory | 1 | 2008 | 349 | 0.060 |
Why?
| Behavior, Animal | 2 | 2006 | 496 | 0.060 |
Why?
| Superoxide Dismutase | 1 | 2007 | 342 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2011 | 2739 | 0.060 |
Why?
| Rats | 1 | 2014 | 5487 | 0.060 |
Why?
| Spinal Cord | 1 | 2007 | 355 | 0.060 |
Why?
| Spleen | 1 | 2006 | 508 | 0.060 |
Why?
| Benzothiazoles | 1 | 2004 | 32 | 0.060 |
Why?
| Genetics, Behavioral | 1 | 2004 | 40 | 0.060 |
Why?
| Flow Cytometry | 1 | 2008 | 1160 | 0.060 |
Why?
| Lysine | 1 | 2006 | 286 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 2016 | 0.060 |
Why?
| Thiazoles | 1 | 2004 | 118 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 756 | 0.050 |
Why?
| Gene Frequency | 2 | 2017 | 500 | 0.050 |
Why?
| Immunoglobulin G | 1 | 2008 | 851 | 0.050 |
Why?
| Memory, Short-Term | 1 | 2006 | 258 | 0.050 |
Why?
| Biological Specimen Banks | 1 | 2024 | 96 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2003 | 109 | 0.050 |
Why?
| Europe | 1 | 2024 | 363 | 0.050 |
Why?
| Diffusion Tensor Imaging | 1 | 2023 | 76 | 0.050 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 98 | 0.050 |
Why?
| West Nile virus | 1 | 2023 | 40 | 0.050 |
Why?
| Growth Disorders | 1 | 2022 | 81 | 0.050 |
Why?
| RNA, Messenger | 1 | 2010 | 2703 | 0.050 |
Why?
| Caspase 3 | 1 | 2023 | 244 | 0.050 |
Why?
| Nuclear Proteins | 1 | 2006 | 660 | 0.050 |
Why?
| Prognosis | 1 | 2010 | 3773 | 0.050 |
Why?
| Models, Biological | 1 | 2009 | 1724 | 0.050 |
Why?
| Pregnancy | 1 | 2014 | 6423 | 0.050 |
Why?
| Viral Load | 1 | 2023 | 449 | 0.040 |
Why?
| United States | 2 | 2015 | 13913 | 0.040 |
Why?
| DNA, Complementary | 1 | 2021 | 266 | 0.040 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 310 | 0.040 |
Why?
| Intracellular Space | 1 | 2020 | 69 | 0.040 |
Why?
| Protein Aggregates | 1 | 2020 | 67 | 0.040 |
Why?
| Acyclovir | 1 | 2020 | 99 | 0.040 |
Why?
| T-Lymphocytes | 1 | 2008 | 1937 | 0.040 |
Why?
| Extracellular Space | 1 | 2020 | 120 | 0.040 |
Why?
| Viral Envelope Proteins | 1 | 2020 | 81 | 0.040 |
Why?
| Child, Preschool | 1 | 2013 | 10522 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 5085 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2022 | 530 | 0.040 |
Why?
| Image Processing, Computer-Assisted | 2 | 2012 | 739 | 0.030 |
Why?
| Cell Membrane | 1 | 2001 | 734 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2010 | 5437 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2017 | 42 | 0.030 |
Why?
| Haplotypes | 1 | 2019 | 474 | 0.030 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 355 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2545 | 0.030 |
Why?
| Linkage Disequilibrium | 1 | 2017 | 257 | 0.030 |
Why?
| Young Adult | 1 | 2013 | 12467 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2017 | 371 | 0.030 |
Why?
| Exome | 1 | 2017 | 216 | 0.030 |
Why?
| Discriminant Analysis | 2 | 2007 | 39 | 0.030 |
Why?
| Genetic Testing | 1 | 2019 | 422 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2019 | 503 | 0.030 |
Why?
| Long-Term Synaptic Depression | 1 | 2016 | 56 | 0.030 |
Why?
| Cell Proliferation | 1 | 2023 | 2378 | 0.030 |
Why?
| Sweden | 1 | 2015 | 93 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 91 | 0.030 |
Why?
| Odds Ratio | 1 | 2017 | 1022 | 0.030 |
Why?
| Antiviral Agents | 1 | 2020 | 719 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2016 | 1092 | 0.030 |
Why?
| Drug Discovery | 1 | 2014 | 131 | 0.030 |
Why?
| Pedigree | 1 | 2015 | 483 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2017 | 2057 | 0.030 |
Why?
| Child | 1 | 2013 | 20962 | 0.030 |
Why?
| Congresses as Topic | 1 | 2014 | 216 | 0.030 |
Why?
| Age of Onset | 1 | 2014 | 494 | 0.030 |
Why?
| Stroke | 1 | 2021 | 1072 | 0.020 |
Why?
| Kinetics | 1 | 2016 | 1645 | 0.020 |
Why?
| Autopsy | 1 | 2012 | 92 | 0.020 |
Why?
| Threonine | 1 | 2011 | 44 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2011 | 156 | 0.020 |
Why?
| Motor Activity | 2 | 2007 | 684 | 0.020 |
Why?
| ROC Curve | 1 | 2012 | 504 | 0.020 |
Why?
| Reference Values | 1 | 2012 | 796 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1686 | 0.020 |
Why?
| Statistics as Topic | 1 | 2011 | 306 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2014 | 1005 | 0.020 |
Why?
| Linear Models | 1 | 2012 | 822 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2011 | 590 | 0.020 |
Why?
| Alleles | 1 | 2012 | 843 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 2011 | 457 | 0.020 |
Why?
| Superoxide Dismutase-1 | 1 | 2007 | 10 | 0.020 |
Why?
| Mice, Neurologic Mutants | 1 | 2007 | 20 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2011 | 1434 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1973 | 0.020 |
Why?
| Random Allocation | 1 | 2007 | 347 | 0.020 |
Why?
| Corticosterone | 1 | 2007 | 220 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 2007 | 313 | 0.020 |
Why?
| RNA | 1 | 2012 | 877 | 0.020 |
Why?
| Social Environment | 1 | 2007 | 293 | 0.020 |
Why?
| Motor Neurons | 1 | 2007 | 233 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 2007 | 1201 | 0.010 |
Why?
| Avoidance Learning | 1 | 2004 | 71 | 0.010 |
Why?
| Space Perception | 1 | 2004 | 79 | 0.010 |
Why?
| Synapses | 1 | 2007 | 397 | 0.010 |
Why?
| Factor Analysis, Statistical | 1 | 2004 | 284 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2004 | 338 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 7158 | 0.010 |
Why?
| Regression Analysis | 1 | 2004 | 998 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 2008 | 0.010 |
Why?
|
|
Potter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|